Article

Urologists may be targeted in second LHRH case

Wilmington, DE-The federal government will likely pursue urologistsin a second round of investigations surrounding the fraudulent marketingand sale of luteinizing hormone-releasing hormone agonists for prostatecancer. Just how far the probe will extend remains a source of debate amonglegal experts familiar with the case.

Related Videos
Raymond Xu, MD, answers a question during a Zoom video interview
Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Jason Hafron, MD, considers the future for AI in urology
Jason Hafron, MD, considers the future for AI in urology
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Timothy Lyon, MD, highlights study assessing accuracy of urology rankings
Timothy D. Lyon, MD, answers a question during a video interview
Expert discusses feasibility of at-home inpatient urologic care
Tania Solomon, PA-C, highlights APP fellowship in urology
Tania Solomon, PA-C, highlights APP fellowship in urology
Modern medical office interior with computer and examination table | Image Credit: © New Africa - stock.adobe.com
The benefits of working with a consultant when starting a private urology practice
Mark Edney, MD, on 3 key principles that improve job satisfaction
Mark Edney, MD, on 3 key principles that improve job satisfaction
Amy M. Pearlman, MD, interviews Gia Ching on Zoom
Amy Pearlman, MD, and Gia Ching on building a personal brand in urology
Chad Ritenour, MD, on efforts to promote physician well-being at Emory Urology
Chad Ritenour, MD, on efforts to promote physician well-being at Emory Urology
Related Content
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
April 14th 2025

Coding Q&A: How to bill for second-generation stone device

Jonathan Rubenstein, MD Mark Painter
Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.
Health policy in urology: 2024 AUA Advocacy Summit recap
March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Closeup financial chart with uptrend line candlestick graph in stock market on blue color monitor background | Image Credit: © iamchamp - stock.adobe.com
March 21st 2025

Money Matters: How to cope with market volatility in 2025

Jeff Witz, CFP
"If you determine you can invest in a volatile environment, the best approach is to do so over a period of time," writes Jeff Witz, CFP.
How APPs can bridge the gap in urologist shortages
August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
Two doctors being discussing patient history | Image Credit: © Freedomz - stock.adobe.com
February 19th 2025

Level of service for vasectomy prompts coding confusion

Jonathan Rubenstein, MD Mark Painter
"With the requirements for an E/M code as noted above, we agree with you that the supporting documentation, if appropriately documented, would support a level 3 outpatient visit for a visit regarding counseling for contraception or family planning," write Jonathan Rubenstein, MD, and Mark Painter.
Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025
February 10th 2025

Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

Arpeet Shah, MD
Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.
© 2025 MJH Life Sciences

All rights reserved.